Found: 86
Select item for more details and to access through your institution.
Characterization of patients with Duchenne muscular dystrophy across previously developed health states.
- Published in:
- PLoS ONE, 2024, v. 19, n. 10, p. 1, doi. 10.1371/journal.pone.0307118
- By:
- Publication type:
- Article
A presynaptic congenital myasthenic syndrome attributed to a homozygous sequence variant in <italic>LAMA5</italic>.
- Published in:
- Annals of the New York Academy of Sciences, 2018, v. 1413, n. 1, p. 119, doi. 10.1111/nyas.13585
- By:
- Publication type:
- Article
Multi-Omics Identifies Circulating miRNA and Protein Biomarkers for Facioscapulohumeral Dystrophy.
- Published in:
- Journal of Personalized Medicine, 2020, v. 10, n. 4, p. 236, doi. 10.3390/jpm10040236
- By:
- Publication type:
- Article
Functional trajectories before and after loss of ambulation in Duchenne muscular dystrophy and implications for clinical trials.
- Published in:
- PLoS ONE, 2024, v. 19, n. 6, p. 1, doi. 10.1371/journal.pone.0304099
- By:
- Publication type:
- Article
Presynaptic congenital myasthenic syndrome with a homozygous sequence variant in LAMA5 combines myopia, facial tics, and failure of neuromuscular transmission.
- Published in:
- American Journal of Medical Genetics. Part A, 2017, v. 173, n. 8, p. 2240, doi. 10.1002/ajmg.a.38291
- By:
- Publication type:
- Article
Survival among patients receiving eteplirsen for up to 8 years for the treatment of Duchenne muscular dystrophy and contextualization with natural history controls.
- Published in:
- Muscle & Nerve, 2024, v. 70, n. 1, p. 60, doi. 10.1002/mus.28075
- By:
- Publication type:
- Article
Treatment effect of idebenone on inspiratory function in patients with Duchenne muscular dystrophy.
- Published in:
- Pediatric Pulmonology, 2017, v. 52, n. 4, p. 508, doi. 10.1002/ppul.23547
- By:
- Publication type:
- Article
Quality-of-Life Measures in Children With Neurological Conditions: Pediatric Neuro-QOL.
- Published in:
- Neurorehabilitation & Neural Repair, 2012, v. 26, n. 1, p. 36, doi. 10.1177/1545968311412054
- By:
- Publication type:
- Article
Delays in pulmonary decline in eteplirsen-treated patients with Duchenne muscular dystrophy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Evaluating longitudinal therapy effects via the North Star Ambulatory Assessment.
- Published in:
- Muscle & Nerve, 2021, v. 64, n. 5, p. 614, doi. 10.1002/mus.27396
- By:
- Publication type:
- Article
(-)-Epicatechin induces mitochondrial biogenesis and markers of muscle regeneration in adults with Becker muscular dystrophy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The CINRG Becker Natural History Study: Baseline characteristics.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The care of patients with Duchenne, Becker, and other muscular dystrophies in the COVID-19 pandemic.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Conference report on contractures in musculoskeletal and neurological conditions.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Deflazacort vs prednisone treatment for Duchenne muscular dystrophy: A meta-analysis of disease progression rates in recent multicenter clinical trials.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Twice‐weekly glucocorticosteroids in infants and young boys with Duchenne muscular dystrophy.
- Published in:
- Muscle & Nerve, 2019, v. 59, n. 6, p. 650, doi. 10.1002/mus.26441
- By:
- Publication type:
- Article
Twice-weekly glucocorticosteroids in infants and young boys with Duchenne muscular dystrophy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Timed function tests have withstood the test of time as clinically meaningful and responsive endpoints in duchenne muscular dystrophy.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Deflazacort versus prednisone/prednisolone for maintaining motor function and delaying loss of ambulation: A post HOC analysis from the ACT DMD trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Mexiletine for muscle cramps in amyotrophic lateral sclerosis: A randomized, double-blind crossover trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Longitudinal community walking activity in Duchenne muscular dystrophy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
In memoriam: William M. Fowler Jr, MD.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Clinical trial readiness in non-ambulatory boys and men with duchenne muscular dystrophy: MDA-DMD network follow-up.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Reachable workspace and performance of upper limb (PUL) in duchenne muscular dystrophy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Outcome reliability in non-Ambulatory Boys/Men with duchenne muscular dystrophy.
- Published in:
- Muscle & Nerve, 2015, v. 51, n. 4, p. 522, doi. 10.1002/mus.24346
- By:
- Publication type:
- Article
THE 6-minute walk test and other endpoints in Duchenne muscular dystrophy: Longitudinal natural history observations over 48 weeks from a multicenter study.
- Published in:
- Muscle & Nerve, 2013, v. 48, n. 3, p. 343, doi. 10.1002/mus.23902
- By:
- Publication type:
- Article
The cooperative international neuromuscular research group Duchenne natural history study--a longitudinal investigation in the era of glucocorticoid therapy: design of protocol and the methods used.
- Published in:
- 2013
- By:
- Publication type:
- journal article
The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: Reliability, concurrent validity, and minimal clinically important differences from a multicenter study.
- Published in:
- Muscle & Nerve, 2013, v. 48, n. 3, p. 357, doi. 10.1002/mus.23905
- By:
- Publication type:
- Article
Why short stature is beneficial in duchenne muscular dystrophy.
- Published in:
- Muscle & Nerve, 2013, v. 48, n. 3, p. 336, doi. 10.1002/mus.23793
- By:
- Publication type:
- Article
The cooperative international neuromuscular research group duchenne natural history study-a longitudinal investigation in the era of glucocorticoid therapy: Design of protocol and the methods used.
- Published in:
- Muscle & Nerve, 2013, v. 48, n. 1, p. 32, doi. 10.1002/mus.23807
- By:
- Publication type:
- Article
The cooperative international neuromuscular research group Duchenne natural history study: Glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other commonly used clinical trial outcome measures
- Published in:
- Muscle & Nerve, 2013, v. 48, n. 1, p. 55, doi. 10.1002/mus.23808
- By:
- Publication type:
- Article
Corticosteroids and duchenne muscular dystrophy: Does earlier treatment really matter?
- Published in:
- Muscle & Nerve, 2012, v. 45, n. 6, p. 777, doi. 10.1002/mus.23304
- By:
- Publication type:
- Article
The 6-minute walk test in Duchenne/Becker muscular dystrophy: Longitudinal observations.
- Published in:
- Muscle & Nerve, 2010, v. 42, n. 6, p. 966, doi. 10.1002/mus.21808
- By:
- Publication type:
- Article
The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy.
- Published in:
- Muscle & Nerve, 2010, v. 41, n. 4, p. 500, doi. 10.1002/mus.21544
- By:
- Publication type:
- Article
Assessment of regional body composition with dual-energy X-ray absorptiometry in Duchenne muscular dystrophy: Correlation of regional lean mass and quantitative strength.
- Published in:
- Muscle & Nerve, 2009, v. 39, n. 5, p. 647, doi. 10.1002/mus.21212
- By:
- Publication type:
- Article
Challenges in drug development for muscle disease: A stakeholders' meeting.
- Published in:
- Muscle & Nerve, 2007, v. 35, n. 1, p. 8, doi. 10.1002/mus.20686
- By:
- Publication type:
- Article
Magnetic resonance imaging of denervated muscle: comparison to electromyography.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Pulmonary Endpoints in Duchenne Muscular Dystrophy. A Workshop Summary.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy: A 30-Month Nonrandomized Controlled Open-Label Extension Trial.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 1, p. e2144178, doi. 10.1001/jamanetworkopen.2021.44178
- By:
- Publication type:
- Article
Assessing the value of delandistrogene moxeparvovec (SRP-9001) gene therapy in patients with Duchenne muscular dystrophy in the United States.
- Published in:
- Journal of Market Access & Health Policy, 2023, v. 11, n. 1, p. 1, doi. 10.1080/20016689.2023.2216518
- By:
- Publication type:
- Article
Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2022, v. 79, n. 10, p. 1005, doi. 10.1001/jamaneurol.2022.2480
- By:
- Publication type:
- Article
Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A Phase 2 Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2020, v. 77, n. 8, p. 982, doi. 10.1001/jamaneurol.2020.1264
- By:
- Publication type:
- Article
Can Quantitative Muscle Strength and Functional Motor Ability Differentiate the Influence of Age and Corticosteroids in Ambulatory Boys with Duchenne Muscular Dystrophy?
- Published in:
- PLoS Currents, 2016, p. 1, doi. 10.1371/currents.md.1ced64dff945f8958221fddcd4ee60b0
- By:
- Publication type:
- Article
Prednisone and Deflazacort in Duchenne Muscular Dystrophy: Do They Play a Different Role in Child Behavior and Perceived Quality of Life?
- Published in:
- PLoS Currents, 2016, p. 331, doi. 10.1371/currents.md.7628d9c014bfa29f821a5cd19723bbaa
- By:
- Publication type:
- Article
The 6-Minute Walk Test and Person-Reported Outcomes in Boys with Duchenne Muscular Dystrophy and Typically Developing Controls: Longitudinal Comparisons and Clinically-Meaningful Changes Over One Year.
- Published in:
- PLoS Currents, 2013, p. 678, doi. 10.1371/currents.md.9e17658b007eb79fcd6f723089f79e06
- By:
- Publication type:
- Article
A Randomized, Double-Blind Trial of Lisinopril and Losartan for the Treatment of Cardiomyopathy in Duchenne Muscular Dystrophy.
- Published in:
- PLoS Currents, 2013, p. 72, doi. 10.1371/currents.md.2cc69a1dae4be7dfe2bcb420024ea865
- By:
- Publication type:
- Article
Percent-Predicted 6-Minute Walk Distance in Duchenne Muscular Dystrophy to Account for Maturational Influences.
- Published in:
- PLoS Currents, 2012, p. 388, doi. 10.1371/currents.RRN1297
- By:
- Publication type:
- Article
Influence of β<sub>1</sub> Adrenergic Receptor Genotype on Longitudinal Measures of Left Ventricular Ejection Fraction and Responsiveness to ß-Blocker Therapy in Patients With Duchenne Muscular Dystrophy.
- Published in:
- Clinical Medicine Insights: Cardiology, 2022, v. 16, p. 1, doi. 10.1177/11795468221116838
- By:
- Publication type:
- Article
Influence of β<sub>1</sub> Adrenergic Receptor Genotype on Longitudinal Measures of Left Ventricular Ejection Fraction and Responsiveness to ß-Blocker Therapy in Patients With Duchenne Muscular Dystrophy.
- Published in:
- Clinical Medicine Insights: Cardiology, 2022, v. 16, p. 1, doi. 10.1177/11795468221116838
- By:
- Publication type:
- Article
Medical management of muscle weakness in Duchenne muscular dystrophy.
- Published in:
- PLoS ONE, 2020, v. 15, n. 10, p. 1, doi. 10.1371/journal.pone.0240687
- By:
- Publication type:
- Article